V

Valley Retina Institute, PA | McAllen, TX

Research site
(Unclaimed)
Location
1309 E. Ridge Road, Suite 1, McAllen, Texas, United States of America

Site insights

Top conditions

Top treatments

APL-2
BI 764524
Vitrase
THR-687
KVD001
Pegcetacoplan
Triamcinolone Acetonide
RBM-007
AR-15512
EYE103

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 26 total trials

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment

Enrolling
Neovascular (Wet) Age-Related Macular Degeneration
Biological: Aflibercept IVT
Biological: 4D-150 IVT

EYE103-101 is a 2-part study assessing safety and preliminary efficacy of EYE103 in patients with diabetic macular edema (DME) given as monotherapy o...

Enrolling
Diabetic Macular Edema (DME)
Neovascular Age-related Macular Degeneration (NVAMD)
Drug: EYE103

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join...

Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

A study to evaluate the safety and efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious posterior segment uve...

Enrolling
Uveitis, Posterior
Drug: Fluocinolone Acetonide Intravitreal Implant 0.18 mg

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic retinopa...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

The purpose of this clinical trial is to compare safety, tolerability, efficacy, and durability of two dose levels of suprachoroidal sustained-releas...

Active, not recruiting
Diabetic Macular Edema
Device: Semi-automated suprachoroidal illuminated microcatheter
Drug: Ozurdex® Ophthalmic Intravitreal Implant

Trial sponsors

A
A
Bausch + Lomb logo
Boehringer Ingelheim logo
T
4
Aerie Pharmaceuticals logo
C
E
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems